Murine Double Minute-2 Inhibition Ameliorates Established Crescentic Glomerulonephritis

American Journal of Pathology

Volumn 186, Issue 6, 2016, Pages 1442-1453

  Mulay, Shrikant R ^a   Romoli, Simone ^a   Desai, Jyaysi ^a   Honarpisheh, Mohammad Mohsen ^a   Kumar, Santhosh V ^a   Anders, Hans Joachim ^a   Thomasova, Dana ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUTLIN 3; PROTEIN MDM2; PROTEIN P53; IMIDAZOLE DERIVATIVE; MDM2 PROTEIN, MOUSE; PIPERAZINE DERIVATIVE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HYPERPLASIA; KIDNEY STRUCTURE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; VASCULAR NECROSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CONFOCAL MICROSCOPY; DISEASE MODEL; GLOMERULONEPHRITIS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-MDM2; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84969813014     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.01.017     Document Type: Article

References (33)

1. G.H. Greenhall, and A.D. Salama What is new in the management of rapidly progressive glomerulonephritis? Clin Kidney J 8 2015 143 150
2. C. Henique, C. Papista, L. Guyonnet, O. Lenoir, and P.L. Tharaux Update on crescentic glomerulonephritis Semin Immunopathol 36 2014 479 490
3. S.V. Kumar, O.P. Kulkarni, S.R. Mulay, M.N. Darisipudi, S. Romoli, D. Thomasova, C.R. Scherbaum, B. Hohenstein, C. Hugo, S. Muller, H. Liapis, and H.J. Anders Neutrophil extracellular trap-related extracellular histones cause vascular necrosis in severe GN J Am Soc Nephrol 26 2015 2399 2413
4. W.G. Couser Basic and translational concepts of immune-mediated glomerular diseases J Am Soc Nephrol 23 2012 381 399
5. M.J. Moeller, and B. Smeets Role of parietal epithelial cells in kidney injury: the case of rapidly progressing glomerulonephritis and focal and segmental glomerulosclerosis Nephron Exp Nephrol 126 2014 97
6. A. Linkermann, B.R. Stockwell, S. Krautwald, and H.J. Anders Regulated cell death and inflammation: an auto-amplification loop causes organ failure Nat Rev Immunol 14 2014 759 767
7. S.R. Mulay, D. Thomasova, M. Ryu, and H.J. Anders MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice Kidney Int 81 2012 1199 1211
8. D. Thomasova, S.R. Mulay, H. Bruns, and H.J. Anders p53-independent roles of MDM2 in NF-kappaB signaling: implications for cancer therapy, wound healing, and autoimmune diseases Neoplasia 14 2012 1097 1101
9. A. Vazquez, E.E. Bond, A.J. Levine, and G.L. Bond The genetics of the p53 pathway, apoptosis and cancer therapy Nat Rev Drug Discov 7 2008 979 987
10. F.S. Leach, T. Tokino, P. Meltzer, M. Burrell, J.D. Oliner, S. Smith, D.E. Hill, D. Sidransky, K.W. Kinzler, and B. Vogelstein p53 Mutation and MDM2 amplification in human soft tissue sarcomas Cancer Res 53 1993 2231 2234
11. L.T. Vassilev, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, C. Klein, N. Fotouhi, and E.A. Liu In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 303 2004 844 848
12. S.R. Mulay, D. Thomasova, M. Ryu, O.P. Kulkarni, A. Migliorini, H. Bruns, R. Grobmayr, E. Lazzeri, L. Lasagni, H. Liapis, P. Romagnani, and H.J. Anders Podocyte loss involves MDM2-driven mitotic catastrophe J Pathol 230 2013 322 335
13. R. Allam, S.G. Sayyed, O.P. Kulkarni, J. Lichtnekert, and H.J. Anders Mdm2 promotes systemic lupus erythematosus and lupus nephritis J Am Soc Nephrol 22 2011 2016 2027
14. K. Suresh An overview of randomization techniques: an unbiased assessment of outcome in clinical research J Hum Reprod Sci 4 2011 8 11
15. European Parliament, Council of the European Union: Directive 2010/63/EU of the European Parliament and of the council of 22 September 2010 on the protection of animals used for scientific purposes. Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:eN:PDF (accessed September 2015)
16. T. Ohse, J.W. Pippin, M.R. Vaughan, P.T. Brinkkoetter, R.D. Krofft, and S.J. Shankland Establishment of conditionally immortalized mouse glomerular parietal epithelial cells in culture J Am Soc Nephrol 19 2008 1879 1890
17. N. Akis, and M.P. Madaio Isolation, culture, and characterization of endothelial cells from mouse glomeruli Kidney Int 65 2004 2223 2227
18. L. Li, D.S. Ng, W.C. Mah, F.F. Almeida, S.A. Rahmat, V.K. Rao, S.C. Leow, F. Laudisi, M.T. Peh, A.M. Goh, J.S. Lim, G.D. Wright, A. Mortellaro, R. Taneja, F. Ginhoux, C.G. Lee, P.K. Moore, and D.P. Lane A unique role for p53 in the regulation of M2 macrophage polarization Cell Death Differ 22 2015 1081 1093
19. R.C. Atkins, D.J. Nikolic-Paterson, Q. Song, and H.Y. Lan Modulators of crescentic glomerulonephritis J Am Soc Nephrol 7 1996 2271 2278
20. G. Bollee, M. Flamant, S. Schordan, C. Fligny, E. Rumpel, M. Milon, E. Schordan, N. Sabaa, S. Vandermeersch, A. Galaup, A. Rodenas, I. Casal, S.W. Sunnarborg, D.J. Salant, J.B. Kopp, D.W. Threadgill, S.E. Quaggin, J.C. Dussaule, S. Germain, L. Mesnard, K. Endlich, C. Boucheix, X. Belenfant, P. Callard, N. Endlich, and P.L. Tharaux Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis Nat Med 17 2011 1242 1250
21. A. Giorgini, H.J. Brown, S.H. Sacks, and M.G. Robson Toll-like receptor 4 stimulation triggers crescentic glomerulonephritis by multiple mechanisms including a direct effect on renal cells Am J Pathol 177 2010 644 653
22. M. Ryu, A. Migliorini, N. Miosge, O. Gross, S. Shankland, P.T. Brinkkoetter, H. Hagmann, P. Romagnani, H. Liapis, and H.J. Anders Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury J Pathol 228 2012 482 494
23. E.M. Sicking, A. Fuss, S. Uhlig, P. Jirak, H. Dijkman, J. Wetzels, D.R. Engel, T. Urzynicok, S. Heidenreich, W. Kriz, C. Kurts, T. Ostendorf, J. Floege, B. Smeets, and M.J. Moeller Subtotal ablation of parietal epithelial cells induces crescent formation J Am Soc Nephrol 23 2012 629 640
24. H.J. Anders, and V. Vielhauer Identifying and validating novel targets with in vivo disease models: guidelines for study design Drug Discov Today 12 2007 446 451
25. G. Liu, Y.J. Park, Y. Tsuruta, E. Lorne, and E. Abraham p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury J Immunol 182 2009 5063 5071
26. T. Hashimoto, T. Ichiki, J. Ikeda, E. Narabayashi, H. Matsuura, R. Miyazaki, K. Inanaga, K. Takeda, and K. Sunagawa Inhibition of MDM2 attenuates neointimal hyperplasia via suppression of vascular proliferation and inflammation Cardiovasc Res 91 2011 711 719
27. C. Ihling, J. Haendeler, G. Menzel, R.D. Hess, G. Fraedrich, H.E. Schaefer, and A.M. Zeiher Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions J Pathol 185 1998 303 312
28. L. Lasagni, E. Lazzeri, S.J. Shankland, H.J. Anders, and P. Romagnani Podocyte mitosis - a catastrophe Curr Mol Med 13 2013 13 23
29. D.N. Muller, R. Dechend, E.M. Mervaala, J.K. Park, F. Schmidt, A. Fiebeler, J. Theuer, V. Breu, D. Ganten, H. Haller, and F.C. Luft NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats Hypertension 35 2000 193 201
30. G.K. Rangan, Y. Wang, Y.C. Tay, and D.C. Harris Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats Kidney Int 56 1999 118 134
31. G.K. Rangan, Y. Wang, Y.C. Tay, and D.C. Harris Early administration of PDTC in adriamycin nephropathy: effect on proteinuria, cortical tubulointerstitial injury, and NF-kappaB activation Ren Fail 23 2001 773 780
32. S. Tamada, T. Nakatani, T. Asai, K. Tashiro, T. Komiya, T. Sumi, M. Okamura, S. Kim, H. Iwao, T. Kishimoto, S. Yamanaka, and K. Miura Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy Kidney Int 63 2003 306 314
33. M.J. Duffy, N.C. Synnott, P.M. McGowan, J. Crown, D. O'Connor, and W.M. Gallagher p53 as a target for the treatment of cancer Cancer Treat Rev 40 2014 1153 1160